new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




  

Curna Inc patents

Recent patent applications related to Curna Inc. Curna Inc is listed as an Agent/Assignee. Note: Curna Inc may have other listings under different names/spellings. We're not affiliated with Curna Inc, we're just tracking patents.

ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "C" | Curna Inc-related inventors




Date Curna Inc patents (updated weekly) - BOOKMARK this page
03/16/17Treatment of collagen gene related diseases by inhibition of natural antisense transcript to a collagen gene
11/24/16Treatment of vascular endothelial growth factor (vegf) related diseases by inhibition of natural antisense transcript to vegf
10/06/16Treatment of pyrroline-5-carboxylate reductase 1 (pycr1) related disease by inhibition of natural antisense transcript to pycr1
09/29/16Treatment of discs large homolog (dlg) related diseases by inhibition of natural antisense transcript to dlg
09/22/16Treatment of colony-stimulating factor 3 (csf3) related diseases by inhibition of natural antisene transcript to csf3
06/16/16Treatment of adiponectin (adipoq) related diseases by inhibition of natural antisense transcript to an adiponectin (adipoq)
06/16/16Treatment of insulin gene (ins) related diseases by inhibition of natural antisense transcript to an insulin gene (ins)
05/19/16Treatment of brain derived neurotrophic factor (bdnf) related diseases by inhibition of natural antisense transcript to bdnf
05/12/16Treatment of alpha-l-iduronidase (idua) related diseases by inhibition of natural antisense transcript to idua
03/31/16Treatment of delta-like 1 homolog (dlk1) related diseases by inhibition of natural antisense transcript to dlk1
02/18/16Treatment of sex hormone binding globulin (shbg) related diseases by inhibition of natural antisense transcript to shbg
01/28/16Treatment of lipid transport and metabolism gene related diseases by inhibition of natural antisense transcript to a lipid transport and metabolism gene
01/28/16Treatment of lipid transport and metabolism gene related diseases by inhibition of natural antisense transcript to a lipid transport and metabolism gene
01/14/16Treatment of tristetraproline (ttp) related diseases by inhibition of natural antisense transcript to ttp
01/07/16Treatment of membrane bound transcription factor peptidase, site 1 (mbtps1) related diseases by inhibition of natural antisense transcript to mbtps1
12/24/15Treatment of interferon-related developmental regulator 1 (ifrd1) related diseases by inhibition of natural antisense transcript to ifrd1
11/26/15Treatment of antiviral gene related diseases by inhibition of natural antisense transcript to an antiviral gene
10/22/15Treatment of reprogramming factor related diseases by inhibition of natural antisense transcript to a reprogramming factor
10/08/15Treatment of sirtuin (sirt) related diseases by inhibition of natural antisense transcript to a sirtuin (sirt)
09/24/15Treatment of sirtuin (sirt) related diseases by inhibition of natural antisense transcript to a sirtuin (sirt)
09/17/15Treatment of uncoupling protein 2 (ucp2) related diseases by inhibition of natural antisense transcript to ucp2
08/20/15Treatment of insulin receptor substrate 2 (irs2) related diseases by inhibition of natural antisense transcript to irs2 and transcription factor e3 (tfe3)
08/13/15Treatment of adiponectin (adipoq) related diseases by inhibition of natural antisense transcript to an adiponectin (adipoq)
08/13/15Treatment of fibroblast growth factor 21 (fgf21) related diseases by inhibition of natural antisense transcript to fgf21
07/16/15Treatment of 'iq motif containing gtpase activating protein' (iqgap) related diseases by inhibition of natural antisense transcript to iqgap
06/18/15Treatment of nanog related diseases by inhibition of natural antisense transcript to nanog
06/18/15Treatment of sialidase 4 (neu4) related diseases by inhibition of natural antisense transcript to neu4
06/11/15Treatment of tumor suppressor gene related diseases by inhibition of natural antisense transcript to the gene
06/04/15Treatment of filaggrin (flg) related diseases by modulation of flg expression and activity
06/04/15Treatment of colony-stimulating factor 3 (csf3) related diseases by inhibition of natural antisense transcript to csf3
06/04/15Treatment of pyrroline-5-carboxylate reductase 1 (pycr1) related diseases by inhibition of natural antisense transcript to pycr1
06/04/15Treatment of methionine sulfoxide reductase a (msra) related diseases by inhibition of natural antisense transcript to msra
06/04/15Treatment of par4 related diseases by inhibition of natural antisense transcript to par4
05/21/15Treatement of vascular endothelial growth factor (vegf) related diseases by inhibition of natural antisense transcript to vegf
05/14/15Treatment of rnase h1 related diseases by inhibition of natural antisense transcript to rnase h1
05/14/15Treatment of discs large homolog (dlg) related diseases by inhibition of natural antisense transcript to dlg
05/07/15Treatment of tumor protein 63 (p63) related diseases by inhibition of natural antisense transcript to p63
04/30/15Treatment of interferon regulatory factor 8 (irf8) related diseases by inhibition of natural antisense transcript to irf8
04/16/15Treatment of paraoxonase 1 (pon1) related diseases by inhibition of natural antisense transcript to pon1
04/02/15Treatment of dystrophin family related diseases by inhibition of natural antisense transcript to dmd family
04/02/15Treatment of hepatocyte growth factor (hgf) related diseases by inhibition of natural antisense transcript to hgf
03/26/15Treatment of erythropoietin (epo) related diseases by inhibition of natural antisense transcript to epo
03/19/15Treatment of transcription factor e3 (tfe3) and insulin receptor substrate 2 (irs2) related diseases by inhibition of natural antisense transcript to tfe3
03/19/15Treatment of nuclear respiratory factor 1 (nrf1) related diseases by inhibition of natural antisense transcript to nrf1
03/12/15Treatment of down syndrome gene related diseases by inhibition of natural antisense transcript to a down syndrome gene
02/26/15Treatment of pancreatic developmental gene related diseases by inhibition of natural antisense transcript to a pancreatic developmental gene
02/05/15Treatment of atonal homolog 1 (atoh1) related diseases by inhibition of natural antisense transcript to atoh1
01/29/15Treatment of brain derived neurotrophic factor (bdnf) related diseases by inhibition of natural antisense transcript to bdnf
12/18/14Treatment of tumor necrosis factor receptor 2 (tnfr2) related diseases by inhibition of natural antisense transcript to tnfr2
10/16/14Treatment of diseases related to alpha subunits of sodium channels, voltage-gated (scnxa) with small molecules
09/25/14Treatment of 'c terminus of hsp70-interacting protein' (chip) related diseases by inhibition of natural antisense transcript to chip
09/25/14Treatment of antiviral gene related diseases by inhibition of natural antisense transcript to an antiviral gene
07/03/14Treatment of frataxin (fxn) related diseases by inhibition of natural antisense transcript to fxn
06/05/14Treatment of tristetraproline (ttp) related diseases by inhibition of natural antisense transcript to ttp
09/26/13Treatment of alpha-l-iduronidase (idua) related diseases by inhibition of natural antisense transcript to idua
09/19/13Antagonat compositions and methods of use
08/15/13Treatment of interferon-related developmental regulator 1 (ifrd1) related diseases by inhibition of natural antisense transcript to ifrd1
06/06/13Treatment of discs large homolog (dlg) related diseases by inhibition of natural antisense transcript to dlg
05/30/13Treatment of glial cell derived neurotrophic factor (gdnf) related diseases by inhibition of natural antisense transcript to gdnf
05/09/13Treatment of membrane bound transcription factor peptidase, site 1 (mbtps1) related diseases by inhibition of natural antisense transcript to mbtps1
04/18/13Treatment of sodium channel, voltage-gated, alpha subunit (scna) related diseases by inhibition of natural antisense transcript to scna
04/04/13Treatment of atonal homolog 1 (atoh1) related diseases by inhibition of natural antisense transcript to atoh1
03/21/13Treatment of sirtuin (sirt) related diseases by inhibition of natural antisense transcript to a sirtuin (sirt)
03/21/13Treatment of methionine sulfoxide reductase a (msra) related diseases by inhibition of natural antisense transcript to msra
02/07/13Treatment of colony-stimulating factor 3 (csf3) related diseases by inhibition of natural antisense transcript to csf3
Patent Packs
02/07/13Treatment of fibroblast growth factor 21 (fgf21) related diseases by inhibition of natural antisense transcript to fgf21
12/27/12Treatment of uncoupling protein 2 (ucp2) related diseases by inhibition of natural antisense transcript to ucp2
12/20/12Treatment of pancreatic developmental gene related diseases by inhibition of natural antisense transcript to a pancreatic developmental gene
12/06/12Treatment of pyrroline-5-carboxylate reductase 1 (pycr1) related diseases by inhibition of natural antisense transcript to pycr1
11/22/12Treatment of filaggrin (flg) related diseases by modulation of flg expression and activity
11/22/12Treatment of rnase h1 related diseases by inhibition of natural antisense transcript to rnase h1
11/15/12Treatment of insulin receptor substrate 2 (irs2) related diseases by inhibition of natural antisense transcript to irs2 and transcription factor e3 (tfe3)
11/01/12Treatment of sex hormone binding globulin (shbg) related diseases by inhibition of natural antisense transcript to shbg
10/18/12Treatment of nuclear respiratory factor 1 (nrf1) related diseases by inhibition of natural antisense transcript to nrf1
11/04/10Treatment of hemoglobin (hbf/hbg) related diseases by inhibition of natural antisense transcript to hbf/hbg
04/29/10Treatment of apolipoprotein-a1 related diseases by inhibition of natural antisense transcript to apolipoprotein-a1







ARCHIVE: New 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Curna Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Curna Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';